# Bluejay Diagnostics, Inc.: filings

BJDX · Nasdaq · CIK 1704287 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bjdx.md) · [Financials](/companies/bjdx/financials.md) · [Filings](/companies/bjdx/filings.md) · [Insiders](/companies/bjdx/insiders.md)

## Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 67, 4 42, 10-Q 15, 3 11, CORRESP 11, SCHEDULE 13G 8, DEF 14A 7, EFFECT 7, UPLOAD 7, PRE 14A 6, 10-K 5, D 5, S-1/A 5, SC 13G 5, SCHEDULE 13G/A 5, S-3 4, 424B3 3, S-1 3, SCHEDULE 13D 3, 10-K/A 2, 424B4 2, 4/A 2, DEFA14A 2, S-8 2, SC 13D 2, SC 13G/A 2, SCHEDULE 13D/A 2, 424B1 1, 424B5 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-13 | 13:09 ET | [8-K](/filings/0001213900-26-108779.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-108779 |
| 2026-10-06 | 13:04 ET | [8-K](/filings/0001213900-26-106999.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-106999 |
| 2026-09-08 | 20:50 ET | [8-K](/filings/0001213900-26-098071.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-098071 |
| 2026-08-13 | 11:56 ET | [8-K](/filings/0001213900-26-088701.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-088701 |
| 2026-08-12 | 20:05 ET | [10-Q](/filings/0001213900-26-088347.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088347 |
| 2026-07-22 | 21:25 ET | [8-K](/filings/0001213900-26-080474.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-080474 |
| 2026-06-09 | 21:26 ET | [8-K](/filings/0001213900-26-066896.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-066896 |
| 2026-06-08 | 21:15 ET | [8-K](/filings/0001213900-26-066364.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-066364 |
| 2026-06-02 | 01:00 ET | [SCHEDULE 13D/A](/filings/0001213900-26-064363.md) | Ownership report, active investor, amended | 0001213900-26-064363 |
| 2026-06-02 | 00:10 ET | [SCHEDULE 13D/A](/filings/0001213900-26-064352.md) | Ownership report, active investor, amended | 0001213900-26-064352 |
| 2026-06-02 | 10:30 ET | [8-K](/filings/0001213900-26-063767.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-063767 |
| 2026-05-07 | 20:13 ET | [10-Q](/filings/0001213900-26-053328.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053328 |
| 2026-05-07 | 20:01 ET | [8-K](/filings/0001213900-26-053295.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-053295 |
| 2026-04-30 | 20:00 ET | [DEF 14A](/filings/0001213900-26-050177.md) | Proxy statement, period 2026-06-09 | 0001213900-26-050177 |
| 2026-04-07 | 13:09 ET | [8-K](/filings/0001213900-26-040728.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-040728 |
| 2026-03-17 | 21:30 ET | [8-K](/filings/0001213900-26-029261.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-029261 |
| 2026-03-16 | 10:07 ET | [8-K](/filings/0001213900-26-027890.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-027890 |
| 2026-03-12 | 16:24 ET | [8-K](/filings/0001213900-26-026749.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-026749 |
| 2026-03-11 | 12:54 ET | [SCHEDULE 13D](/filings/0001213900-26-025973.md) | Ownership report, active investor | 0001213900-26-025973 |
| 2026-03-11 | 12:12 ET | [SCHEDULE 13D](/filings/0001213900-26-025962.md) | Ownership report, active investor | 0001213900-26-025962 |
| 2026-03-11 | 10:40 ET | [SCHEDULE 13D](/filings/0001213900-26-025920.md) | Ownership report, active investor | 0001213900-26-025920 |
| 2026-03-06 | 21:02 ET | [10-K](/filings/0001213900-26-024616.md) | Annual report, period 2025-12-31 | 0001213900-26-024616 |
| 2026-03-06 | 14:21 ET | [8-K](/filings/0001213900-26-024352.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-024352 |
| 2026-02-20 | 14:54 ET | [8-K](/filings/0001213900-26-018638.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-018638 |
| 2026-02-18 | 02:54 ET | [8-K](/filings/0001213900-26-017641.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-017641 |
| 2026-01-30 | 02:14 ET | [8-K](/filings/0001213900-26-009792.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-009792 |
| 2025-12-30 | 14:16 ET | [8-K](/filings/0001213900-25-126358.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-126358 |
| 2025-11-10 | 21:00 ET | [8-K](/filings/0001213900-25-108192.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108192 |
| 2025-11-07 | 21:01 ET | [10-Q](/filings/0001213900-25-107599.md) | Quarterly report, period 2025-09-30 | 0001213900-25-107599 |
| 2025-10-14 | 10:16 ET | [8-K](/filings/0001213900-25-098281.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098281 |
| 2025-10-09 | 10:05 ET | [8-K](/filings/0001213900-25-097564.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-097564 |
| 2025-08-15 | 21:27 ET | [8-K](/filings/0001213900-25-077600.md) | 8.01 Other events | 0001213900-25-077600 |
| 2025-08-11 | 01:40 ET | [8-K](/filings/0001213900-25-073870.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-073870 |
| 2025-08-07 | 20:01 ET | [10-Q](/filings/0001213900-25-073064.md) | Quarterly report, period 2025-06-30 | 0001213900-25-073064 |
| 2025-07-28 | 21:10 ET | [8-K](/filings/0001213900-25-068296.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-068296 |
| 2025-06-20 | 22:54 ET | [8-K](/filings/0001213900-25-055724.md) | 5.07 Shareholder vote results | 0001213900-25-055724 |
| 2025-06-04 | 00:19 ET | [8-K](/filings/0001213900-25-050913.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-050913 |
| 2025-05-28 | 21:18 ET | [8-K](/filings/0001213900-25-048343.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-048343 |
| 2025-05-16 | 21:00 ET | [DEF 14A](/filings/0001213900-25-044931.md) | Proxy statement, period 2025-06-18 | 0001213900-25-044931 |
| 2025-05-13 | 20:01 ET | [10-Q](/filings/0001213900-25-042633.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042633 |
| 2025-04-29 | 20:00 ET | [10-K/A](/filings/0001213900-25-036783.md) | Annual report, amended, period 2024-12-31 | 0001213900-25-036783 |
| 2025-04-09 | 20:15 ET | [8-K](/filings/0001213900-25-030312.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-030312 |
| 2025-03-31 | 20:18 ET | [10-K](/filings/0001213900-25-026275.md) | Annual report, period 2024-12-31 | 0001213900-25-026275 |
| 2024-12-04 | 22:26 ET | [8-K](/filings/0001213900-24-105693.md) | 8.01 Other events | 0001213900-24-105693 |
| 2024-11-18 | 11:30 ET | [8-K](/filings/0001213900-24-099327.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-099327 |
| 2024-11-07 | 21:00 ET | [10-Q](/filings/0001213900-24-095388.md) | Quarterly report, period 2024-09-30 | 0001213900-24-095388 |
| 2024-10-24 | 10:59 ET | [8-K](/filings/0001213900-24-090120.md) | 5.07 Shareholder vote results | 0001213900-24-090120 |
| 2024-10-16 | 20:55 ET | [8-K](/filings/0001213900-24-088196.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-088196 |
| 2024-09-10 | 22:04 ET | [DEF 14A](/filings/0001213900-24-077413.md) | Proxy statement, period 2024-10-23 | 0001213900-24-077413 |
| 2024-08-28 | 21:24 ET | [8-K](/filings/0001213900-24-073437.md) | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-073437 |

Page 1 of 3. [Older](/companies/bjdx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.